Selective Serotonin Reuptake Inhibitors and Cytochrome P-450 Mediated Drug-Drug Interactions: An Update

Publisher： Bentham Science Publishers

E-ISSN： 1875-5453|3|1|13-37

ISSN： 1389-2002

Source： Current Drug Metabolism, Vol.3, Iss.1, 2002-02, pp. : 13-37

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Cytochrome P450-mediated cardiovascular drug interactions

By Scheen André J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 9, 2011-09 ,pp. : 1065-1082

Informa Healthcare

Access to resources Recommend Favorite

Selective Serotonin Reuptake Inhibitors (SSRIs): Therapeutic Drug Monitoring and Pharmacological Interactions

By  

Current Medicinal Chemistry, Vol. 19, Iss. 12, 2012-04 ,pp. : 1846-1863

Bentham Science Publishers

Access to resources Recommend Favorite

Ximelagatran, an Oral Direct Thrombin Inhibitor, Has a Low Potential for Cytochrome P450-Mediated Drug-Drug Interactions

By Bredberg E.   Andersson T.B.   Frison L.   Thuresson A.   Johansson S.   Eriksson-Lepkowska M.   Larsson M.   Eriksson U.G.  

Clinical Pharmacokinetics, Vol. 42, Iss. 8, 2003-01 ,pp. : 765-777

Adis International

Access to resources Recommend Favorite

The role of cytochrome P450-mediated drug-drug interactions in determining the safety of statins

By Worz Chad R   Bottorff Michael  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 7, 2001-07 ,pp. : 1119-1127

Informa Healthcare

Access to resources Recommend Favorite

Emerging In Vitro Tools to Evaluate Cytochrome P450 and Transporter-Mediated Drug-Drug Interactions

By  

Current Drug Discovery Technologies, Vol. 7, Iss. 3, 2010-09 ,pp. : 199-222

Bentham Science Publishers

Access to resources Recommend Favorite